Insiderkauf

Amylyx Pharmaceuticals

AMLX

Insidertransaktionen und Aktienkurs 2024-2026

Alle Insidertrades bei Amylyx Pharmaceuticals

RSS abonnieren
Datum Typ Insider Position Ø-Preis Volumen
10.7.2026 Verkauf Mazzariello, Gina Chief Legal Officer 17,6 $ 264.122 $
9.7.2026 Verkauf Mazzariello, Gina Chief Legal Officer 18,3 $ 274.746 $
21.5.2026 Kauf Firestone, Karen Aufsichtsrat 13,5 $ 51.338 $
2.3.2026 Verkauf Mazzariello, Gina Chief Legal Officer 14,5 $ 99.378 $
2.3.2026 Verkauf Frates, James M. Chief Financial Officer 14,5 $ 114.851 $
2.3.2026 Verkauf Bedrosian, Camille L. Chief Medical Officer 14,6 $ 94.205 $
2.3.2026 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 14,5 $ 424.120 $
2.3.2026 Verkauf Klee, Justin B. Co-Chief Executive Officer 14,5 $ 423.760 $
23.2.2026 Verkauf Mazzariello, Gina Chief Legal Officer 14,1 $ 48.352 $
2.2.2026 Verkauf Klee, Justin B. Co-Chief Executive Officer 14,7 $ 227.618 $
2.2.2026 Verkauf Mazzariello, Gina Chief Legal Officer 14,7 $ 50.516 $
2.2.2026 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 14,7 $ 227.593 $
2.2.2026 Verkauf Frates, James M. Chief Financial Officer 14,6 $ 52.097 $
16.1.2026 Verkauf Klee, Justin B. Co-Chief Executive Officer 13,9 $ 27.701 $
16.1.2026 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 13,8 $ 27.299 $
15.1.2026 Verkauf Klee, Justin B. Co-Chief Executive Officer 13,6 $ 1.849.869 $
15.1.2026 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 13,6 $ 1.850.795 $
6.1.2026 Verkauf Klee, Justin B. Co-Chief Executive Officer 11,1 $ 85.589 $
6.1.2026 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 11,1 $ 85.596 $
6.1.2026 Verkauf Frates, James M. Chief Financial Officer 11,1 $ 36.954 $
23.12.2025 Kauf Firestone, Karen Aufsichtsrat 12,4 $ 100.845 $
1.12.2025 Verkauf Bedrosian, Camille L. Chief Medical Officer 14,3 $ 94.418 $
30.9.2025 Verkauf Bedrosian, Camille L. Chief Medical Officer 14,6 $ 175.518 $
30.9.2025 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 14,7 $ 429.469 $
30.9.2025 Verkauf Frates, James M. Chief Financial Officer 14,6 $ 154.650 $
30.9.2025 Verkauf Mazzariello, Gina Chief Legal Officer 14,6 $ 128.669 $
30.9.2025 Verkauf Klee, Justin B. Co-Chief Executive Officer 14,7 $ 430.952 $
13.8.2025 Verkauf Mazzariello, Gina Chief Legal Officer 8,3 $ 125.046 $
12.8.2025 Verkauf Mazzariello, Gina Chief Legal Officer 8,1 $ 121.102 $
31.3.2025 Verkauf Klee, Justin B. Co-Chief Executive Officer 3,5 $ 74.454 $
31.3.2025 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 3,5 $ 74.482 $
31.3.2025 Verkauf Mazzariello, Gina Chief Legal Officer 3,5 $ 31.954 $
31.3.2025 Verkauf Bedrosian, Camille L. Chief Medical Officer 3,5 $ 43.082 $
31.3.2025 Verkauf Frates, James M. Chief Financial Officer 3,5 $ 37.806 $
20.3.2025 Kauf Zeiher, Bernhardt G. Aufsichtsrat 3,7 $ 37.005 $
3.3.2025 Verkauf Mazzariello, Gina Chief Legal Officer 3,1 $ 5.022 $
3.3.2025 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 3,2 $ 14.549 $
3.3.2025 Verkauf Klee, Justin B. Co-Chief Executive Officer 3,2 $ 14.483 $
24.2.2025 Verkauf Mazzariello, Gina Chief Legal Officer 3,2 $ 13.145 $
3.2.2025 Verkauf Klee, Justin B. Co-Chief Executive Officer 3,5 $ 41.104 $
3.2.2025 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 3,5 $ 41.108 $
3.2.2025 Verkauf Mazzariello, Gina Chief Legal Officer 3,5 $ 12.839 $
6.1.2025 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 4,0 $ 30.232 $
6.1.2025 Verkauf Klee, Justin B. Co-Chief Executive Officer 4,0 $ 30.202 $
2.12.2024 Verkauf Bedrosian, Camille L. Chief Medical Officer 5,5 $ 30.007 $
30.9.2024 Verkauf Mazzariello, Gina Chief Legal Officer 3,2 $ 27.840 $
30.9.2024 Verkauf Bedrosian, Camille L. Chief Medical Officer 3,2 $ 36.559 $
30.9.2024 Verkauf Cohen, Joshua B. Co-Chief Executive Officer 3,2 $ 59.414 $
30.9.2024 Verkauf Klee, Justin B. Co-Chief Executive Officer 3,2 $ 59.429 $
12.9.2024 Kauf Frates, James M. Chief Financial Officer 2,5 $ 101.368 $
5.9.2024 Kauf Firestone, Karen Aufsichtsrat 2,1 $ 106.590 $
3.9.2024 Kauf Milne, George M Jr Aufsichtsrat 2,2 $ 219.800 $
Rows per page:
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)